1. Home
  2. Azioni
  3. Australia
  4. Australian Stock Exchange
  5. Next Science Limited
  6. Notizie
  7. Altre lingue
    NXS   AU0000041329

NEXT SCIENCE LIMITED

(NXS)
  Rapporto
Tempo differito Australian Stock Exchange  -  07:59 06/07/2022
0.8150 AUD   -3.55%
27/05Il prossimo CEO di Science si dimetterà prima del 30 giugno 2023
MT
27/05Judith Mitchell di Next Science Limited si dimette da Amministratore Delegato
CI
19/05Next Science si assicura un distributore in Australia e Nuova Zelanda per un prodotto di medicazione per ferite.
MT
RiassuntoQuotazioniGraficiNotizieRatingCalendarioSocietąFinanzaConsensusRevisioniDerivati 
RiassuntoTutte le notizieAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su NEXT SCIENCE LIMITED
27/05Next Science CEO to Resign Before June 30, 2023
27/05Next Science Limited's Judith Mitchell to Step Down as Chief Executive Officer
27/05TRANSCRIPT: Next Science Limited - Shareholder/Analyst Call
19/05Next Science Secures Australia, New Zealand Distributor for Wound Dressing Product
19/05Next Science Limited Signed Multi-Year Distribution Agreement with Oraderm Pharmaceutic..
10/05New Study Finds XPERIENCE™ No Rinse Solution Has Persistent Efficacy Against Both..
10/05Next Science Xperience(Tm) No Rinse Solution Shows Persistent Efficacy Against Both Pla..
28/04Australian Shares End Three-Day Losing Streak on Boost from Miners
28/04Next Science Posts 31% Growth in Q1 Product Revenue
28/04NEXT SCIENCE: Investor Presentation - Q1 2022
22/04NEXT SCIENCE: 2022 Corporate Governance Statement & Appendix 4G
22/04NEXT SCIENCE: 2022 agm
22/03Next Science Completes Share Purchase Plan; Shares Up 3%
22/03NEXT SCIENCE: Successful completion of Share Purchase Plan
04/03Next Science Opens Nearly $4 Million Share Purchase Plan
02/03NEXT SCIENCE: Application for quotation of securities - NXS
28/02TRANSCRIPT: Next Science Limited, 2021 Earnings Call, Feb 28, 2022
24/02NEXT SCIENCE: Proposed issue of securities - NXS
23/02NEXT SCIENCE: Appendix 4E / FY21 Financial Statements
23/02Next Science Limited Reports Earnings Results for the Full Year Ended December 31, 2021
01/02NEXT SCIENCE: Application for quotation of securities - NXS
30/01NEXT SCIENCE: Investor Presentation - Q4 FY21
30/01Next Science Limited Signs Sales & Distribution Relationship Agreement with Zimmer, Inc
2021Next Science Secures Australian Regulatory Clearance for Surgical Cleanser Product
2021Next Science Limited's Xperiencetm Cleared by TGA for Sale in Australia
2021TELA Bio and Next Science Enter into Exclusive Distribution Agreement in the Plastic Re..
2021TELA Bio Receives Exclusive Rights to Sell Next Science Antimicrobial Surgical Wash in ..
2021Next Science Signs Distribution Deal for Antimicrobial Cleaning Product
2021Next Science Limited Signs Multi-Year Distribution Agreement with Tela Bio, Inc
2021TRANSCRIPT: Next Science Limited, H1 2021 Earnings Call, Aug 30, 2021
2021Next Science Limited Announces Half Year Report for the Six Months Ended 30 June 2021
2021NEXT SCIENCE: to Exhibit Surgical Product Portfolio at AAOS 2021
2021NEXT SCIENCE: Begins U.S. Clinical Trial for XPERIENCE No Rinse Antimicrobial Solution
2021Next Science Limited Begins U.S. Clinical Trial for XPERIENCE No Rinse Antimicrobial So..
2021NEXT SCIENCE: Revenue Soars 271% in H1; Shares Rise 5%
2021NEXT SCIENCE: Product Featured in Lifetime Channel Program on Treating Chronic Wounds
2021NEXT SCIENCE: Revises Revenue Guidance for H1 CY2021
2021Next Science Limited Provides Revenue Guidance for the First Half of 2021
2021NEXT SCIENCE: Antimicrobial Wound Gel Gets Sale Clearance from Australian Drug Regulator
2021Next Science Limited Receives Approval for BlastX from Therapeutic Goods Administration..
2021TRANSCRIPT: Next Science Limited - Shareholder/Analyst Call
2021Next Science’s XPERIENCE No Rinse Antimicrobial Solution Cleared by FDA for Sale in USA
2021NEXT SCIENCE: 's XPERIENCE No Rinse Antimicrobial Solution Cleared by FDA for Sale in USA
2021Australian Shares Post Moderate Loss Amid Lockdown in Some Western Australian Areas
2021NEXT SCIENCE: Receives FDA Clearance for Surgical Antimicrobial Product; Shares Surge 27%
2021Next Science Limited Announces XPerience No Rinse Antimicrobial Solution Cleared by FDA..
20215,850,000 Options of Next Science Limited are subject to a Lock-Up Agreement Ending on ..
202172,847,808 Ordinary Shares of Next Science Limited are subject to a Lock-Up Agreement E..
2021Next Science Limited Announces Changes to Board of Directors
2021NEXT SCIENCE LIMITED(ASX: NXS) dropped from S&P/ASX All Ordinaries Index
2021TRANSCRIPT: Next Science Limited, 2020 Earnings Call, Feb 23, 2021
2021NEXT SCIENCE: Net Loss Contracts in FY20
2021Next Science Limited Announces Consolidated Earnings Results for the Year Ended Decembe..
2021REUTERS NEXT-Science must determine company climate targets, say executives
2020NEXT SCIENCE: Lands CE Mark in Europe for Antimicrobial Wound Gel BlastX; Shares Up 6%
2020Next Science Limited Receives CE Mark Approval for BlastX
2020NEXT SCIENCE: and 3M Donate $300,000 of Breakthrough Wound Treatment to Jacksonville-Area..
2020NEXT SCIENCE: 3M Decide Not to Renew BlastX Distribution Contract; Shares Fall 9%
2020Next Science Limited Announces Non-Renewal of Distribution Agreement With 3M
2020TRANSCRIPT: Next Science Limited - Shareholder/Analyst Call
2020NEXT SCIENCE: and 3M Donate $300,000 of Breakthrough Wound Treatment to New Jersey Nursin..
2020NEXT SCIENCE LIMITED(ASX: NXS) dropped from S&P Global BMI Index
2020Next Science Limited Announces Update on XPerience FDa Approval Process
2020TRANSCRIPT: Next Science Limited, H1 2020 Earnings Call, Aug 26, 2020
2020Next Science Limited Reports Earnings Results for the Half Year Ended June 30, 2020
2020Next Science Limited Receives Therapeutic Goods Administration Approval for Bactisure S..
2020NEXT SCIENCE LIMITED(ASX: NXS) added to S&P/ASX All Ordinaries Index
2020NEXT SCIENCE LIMITED(ASX: NXS) added to S&P/ASX Emerging Companies Index
2020TRANSCRIPT: Next Science Limited - Shareholder/Analyst Call
2020Next Science Limited Reports Audited Consolidated and Parent Earnings Results for the Y..
2020Next Science Limited Receives EPS Approval for Surface Disinfectant
2020Next Science Limited Announces Launch of Online Sales of Acne Cream
2020TRANSCRIPT: Next Science Limited, 2019 Earnings Call, Feb 28, 2020
2020Next Science Limited Plan to Launch 5 New Products in 2020
2020Next Science Limited Reports Earnings Results for the Full Year Ended December 31, 2019
1  2Succ.